Andrew Hykes - 07 Jun 2022 Form 4 Insider Report for Inari Medical, Inc.

Role
Chief Operating Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
07 Jun 2022
Net transactions value
-$350,390
Form type
4
Filing time
09 Jun 2022, 16:34:12 UTC
Previous filing
04 May 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $350,390 -5,000 -3.3% $70.08 146,984 07 Jun 2022 Direct F1, F2
holding NARI Common Stock 1,550 07 Jun 2022 By Child 1
holding NARI Common Stock 1,550 07 Jun 2022 By Child 2
holding NARI Common Stock 1,550 07 Jun 2022 By Child 3
holding NARI Common Stock 1,000 07 Jun 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $70.00 to $70.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.